FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040147197> ?p ?o ?g. }

• W2040147197 endingPage "235" @default.
• W2040147197 startingPage "231" @default.
• W2040147197 abstract "Abstract: Mycophenolate mofetil (MMF) is a new immunosuppressive drug used in combination with cyclosporin A (CsA) or tacrolimus and prednisone to prevent rejection of renal allografts in both adult and pediatric recipients. It has been shown in several large studies that MMF significantly decreases the incidence of acute rejection in adults and has acceptable adverse effects. In this retrospective study, we compare the incidence of adverse events between pediatric and adult renal allograft recipients. Twenty-two children and 37 adult renal allograft recipients were included in the study. The initial dose of MMF was 1.5 g b.i.d. for the adult patients and ranged from 15 to 30 mg/kg/d for the pediatric patients. All patients received p.o. acyclovir as prophylaxis for cytomegalovirus (CMV). The two groups were similar regarding gender distribution and graft source. Acute rejections occurred in 10 of the 22 pediatric patients (45%) and in nine of the 37 adults (24%), p = NS. The incidence of infections was similar in both groups except for the occurrence of CMV (n = 5), which was seen only in adults. The incidence of GI symptoms was significantly higher in the pediatric population (54.5% vs. 21.6%; p = 0.02). Significant weight loss was seen more often in the smaller pediatric patients (weight ≤ 15 kg) compared to the larger pediatric patients, 60% vs. 11.7%, p = 0.05. Among the patients who had significant GI symptoms 50% of the adults and 75% of the pediatric recipients required either dose reduction or, most commonly, discontinuation of the MMF. The need to discontinue MMF was significantly higher in the pediatric patients, especially in those that weighed less than 15 kg. We suggest the possibility that the optimum dose, dosing interval or preparation of MMF has not yet been established for pediatric patients. One should therefore monitor pediatric patients closely, especially the small ones, to avoid significant nutritional problems and other adverse GI events." @default.
• W2040147197 created "2016-06-24" @default.
• W2040147197 creator A5007628500 @default.
• W2040147197 creator A5074623407 @default.
• W2040147197 date "1999-08-01" @default.
• W2040147197 modified "2023-09-25" @default.
• W2040147197 title "A comparative analysis of the use of mycophenolate mofetil in pediatric vs. adult renal allograft recipients" @default.
• W2040147197 cites W1891570058 @default.
• W2040147197 cites W1979599521 @default.
• W2040147197 cites W2021142445 @default.
• W2040147197 cites W2055704616 @default.
• W2040147197 cites W2063929233 @default.
• W2040147197 cites W2074567821 @default.
• W2040147197 cites W2151455000 @default.
• W2040147197 cites W2609602266 @default.
• W2040147197 cites W4230996310 @default.
• W2040147197 cites W50336179 @default.
• W2040147197 doi "https://doi.org/10.1034/j.1399-3046.1999.00041.x" @default.
• W2040147197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10487285" @default.
• W2040147197 hasPublicationYear "1999" @default.
• W2040147197 type Work @default.
• W2040147197 sameAs 2040147197 @default.
• W2040147197 citedByCount "22" @default.
• W2040147197 countsByYear W20401471972017 @default.
• W2040147197 countsByYear W20401471972022 @default.
• W2040147197 crossrefType "journal-article" @default.
• W2040147197 hasAuthorship W2040147197A5007628500 @default.
• W2040147197 hasAuthorship W2040147197A5074623407 @default.
• W2040147197 hasConcept C120665830 @default.
• W2040147197 hasConcept C121332964 @default.
• W2040147197 hasConcept C126322002 @default.
• W2040147197 hasConcept C126894567 @default.
• W2040147197 hasConcept C141071460 @default.
• W2040147197 hasConcept C197934379 @default.
• W2040147197 hasConcept C2778033501 @default.
• W2040147197 hasConcept C2778720950 @default.
• W2040147197 hasConcept C2909675724 @default.
• W2040147197 hasConcept C2909935303 @default.
• W2040147197 hasConcept C2911091166 @default.
• W2040147197 hasConcept C61511704 @default.
• W2040147197 hasConcept C71924100 @default.
• W2040147197 hasConcept C90924648 @default.
• W2040147197 hasConceptScore W2040147197C120665830 @default.
• W2040147197 hasConceptScore W2040147197C121332964 @default.
• W2040147197 hasConceptScore W2040147197C126322002 @default.
• W2040147197 hasConceptScore W2040147197C126894567 @default.
• W2040147197 hasConceptScore W2040147197C141071460 @default.
• W2040147197 hasConceptScore W2040147197C197934379 @default.
• W2040147197 hasConceptScore W2040147197C2778033501 @default.
• W2040147197 hasConceptScore W2040147197C2778720950 @default.
• W2040147197 hasConceptScore W2040147197C2909675724 @default.
• W2040147197 hasConceptScore W2040147197C2909935303 @default.
• W2040147197 hasConceptScore W2040147197C2911091166 @default.
• W2040147197 hasConceptScore W2040147197C61511704 @default.
• W2040147197 hasConceptScore W2040147197C71924100 @default.
• W2040147197 hasConceptScore W2040147197C90924648 @default.
• W2040147197 hasIssue "3" @default.
• W2040147197 hasLocation W20401471971 @default.
• W2040147197 hasLocation W20401471972 @default.
• W2040147197 hasOpenAccess W2040147197 @default.
• W2040147197 hasPrimaryLocation W20401471971 @default.
• W2040147197 hasRelatedWork W2011298598 @default.
• W2040147197 hasRelatedWork W2042268211 @default.
• W2040147197 hasRelatedWork W2078718522 @default.
• W2040147197 hasRelatedWork W2118272408 @default.
• W2040147197 hasRelatedWork W2135234309 @default.
• W2040147197 hasRelatedWork W2170843252 @default.
• W2040147197 hasRelatedWork W2314615787 @default.
• W2040147197 hasRelatedWork W4229643107 @default.
• W2040147197 hasRelatedWork W4245234640 @default.
• W2040147197 hasRelatedWork W4317938503 @default.
• W2040147197 hasVolume "3" @default.
• W2040147197 isParatext "false" @default.
• W2040147197 isRetracted "false" @default.
• W2040147197 magId "2040147197" @default.
• W2040147197 workType "article" @default.